Table 2.
Hematological biomarkers according to risk groups (n = 60).
|
Variable |
Low risk Group (a) (n = 20) |
Intermediate low risk Group (b) (n = 10) |
Intermediate high risk Group (c) (n = 10) |
High risk group (d) (n = 20) |
P |
|---|---|---|---|---|---|
|
TLC(10³/ul): Mean ± SD |
8.3 ± 2.1 | 8.3 ± 2.7 | 8.4 ± 2.4 | 8.5 ± 2.5 | 0.99 (NS) |
|
Neutrophils (10³/ul): Mean ± SD |
7.6 ± 1.9 | 8.1 ± 2.2 | 8.2 ± 2.9 | 8.6 ± 2.3 | 0.59 (NS) |
|
Lymphocytes (10³/ul): Mean ± SD |
a,b 1.7 ± 0.6 |
a,b,c,d 1.3 ± 0.6 |
b,c,d 1.1 ± 0.5 |
b,c,d 0.9 ± 0.4 |
0.001 (S) |
|
NLR: Mean ± SD |
a,b 4.9 ± 2.4 |
a,b 6.8 ± 2.6 |
c,d 8.4 ± 4.2 |
c,d 10 ± 3.9 |
<0.001 (HS) |
|
Hemoglobin (g/dl): Mean ± SD |
13.1 ± 1.7 | 13.8 ± 1.5 | 12.7 ± 2.1 | 13.2 ± 1.8 | 0.56 (NS) |
|
Hematocrit (%): Mean ± SD |
37.4 ± 7.4 | 37.6 ± 6.6 | 36.8 ± 8.4 | 36.7 ± 6.9 | 0.985 (NS) |
|
HHR: Mean ± SD |
2.8 ± 0.2 | 2.6 ± 0.2 | 2.8 ± 0.2 | 2.7 ± 0.2 | 0.213 (NS) |
|
PLT(10³/ul): Mean ± SD |
257.1 ± 73 | 253.1 ± 95 | 249.7 ± 91 | 247.2 ± 70 | 0.98 (NS) |
|
PLR: Mean ± SD |
a,b 171.1 ± 65 |
a,b,c 205.8 ± 76 |
b,c,d 228.6 ± 84 |
b,c,d 262.7 ± 85 |
0.005 (S) |
|
Albumin (g/dl): Mean ± SD |
a,b 3.9 ± 0.7 |
a,b,c 3.7 ± 0.8 |
b,c,d 3.2 ± 0.6 |
c,d 3.1 ± 0.5 |
0.001 (S) |
|
ALT(U/L): Mean ± SD |
25.4 ± 10 | 32.3 ± 20 | 29.8 ± 21 | 23.2 ± 9 | 0.39 (NS) |
|
AST(U/L): Mean ± SD |
28.9 ± 11.7 | 35.4 ± 29.2 | 31.3 ± 11.5 | 31.9 ± 21.8 | 0.86 (NS) |
|
BUN(mg/dl): Mean ± SD |
a,b,c 18.2 ± 5.7 |
a,b,c 20.7 ± 13.5 |
a,b,c,d 25.1 ± 9 |
c,d 29.9 ± 10.3 |
0.002 (S) |
|
Creatinine (mg/dl): Mean ± SD |
0.79 ± 0.2 | 0.81 ± 0.5 | 0.84 ± 0.3 | 0.81 ± 0.3 | 0.99 (NS) |
|
B/A (mg/g): Mean ± SD |
a,b 4.7 ± 1.5 |
a,b,c 5.2 ± 2.4 |
b,c,d 7.8 ± 2.6 |
c,d 10.1 ± 4 |
<0.001 (HS) |
|
PT(Sec): Mean ± SD |
13.3 ± 1.9 | 14.5 ± 2.2 | 13.8 ± 1.8 | 14.8 ± 2.1 | 0.12 (NS) |
|
PTT(Sec): Mean ± SD |
31.5 ± 4.1 | 30.1 ± 5.8 | 30.7 ± 5.1 | 30.4 ± 0.9 | 0.83 (NS) |
|
INR: Mean ± SD |
1.06 ± 0.1 | 1.1 ± 0.1 | 1.1 ± 0.1 | 1.1 ± 0.1 | 0.38 (NS) |
|
CRP(mg/l): Mean ± SD |
a,b 6.6 ± 4 |
a,b,c 8.9 ± 4.8 |
b,c 11.4 ± 4.6 |
d 13.5 ± 7.1 |
0.002 (S) |
|
Troponin I(ng/ml): Mean ± SD |
a,b 0.09 ± 0.06 |
a,b 0.1 ± 0.05 |
c 0.7 ± 0.4 |
d 1.4 ± 0.6 |
<0.001 (HS) |
|
BNP (pg/ml): Mean ± SD |
a,b 125.3 ± 40.5 |
a,b,c 162.7 ± 67.8 |
b,c 237 ± 57.3 |
d 416.5 ± 141.3 |
<0.001 (HS) |
|
HFABP(ng/ml) Negative (14): Positive (≥6) (46): |
7 (35 %) 13 (65 %) |
3 (30 %) 7 (70 %) |
2 (20 %) 8 (80 %) |
2 (10 %) 18 (90 %) |
0.28 (NS) |
|
D-Dimer (ng/ml): Mean ± SD |
a,b 683 ± 132.5 |
a,b,c 786 ± 198.2 |
b,c,d 909 ± 270 |
c,d 1003 ± 353.2 |
0.002 (S) |
|
IMA (ng/ml): Mean ± SD |
2189 ± 724 | 2215 ± 905 | 2309 ± 770 | 2388 ± 776 | 0.86 (NS) |
Data represented as frequency (percentage), mean, and (SD).
NS non-significant difference (p > 0.05), S statistically significant (P < 005), HS Highly statistically significant (P < 0.001), Different letters denote significant difference.
TLC Total leucocyte count, NLR neutrophil/lymphocyte ratio, HHR hematocrit to hemoglobin ratio, PLT platelet, PLR platelet/lymphocyte ratio, ALT Alanine transaminase, AST Aspartate aminotransferase, BUN blood urea nitrogen, B/A BUN/albumin ratio, PT prothrombin time, PTT partial thromboplastin time, INR international normalized ratio, CRP C-reactive protein, BNP Brain natriuretic peptide, HFABP Heart type fatty acid binding protein, IMA ischemia modified albumin.